The National Cancer Institute approved the following clinical research studies last month.
For further information, contact the principal investigator listed.
Phase I – PED-CITN-01
3CI Study: Childhood Cancer Combination Immunotherapy. Phase Ib and Expansion Study of Nivolumab Combination Immunotherapy in Children, Adolescent and Young Adult (CAYA) Patients with Relapsed/Refractory Hypermutant Cancers
Cancer Immunotherapy Trials Network
Morgenstern, Daniel Alexander
(416) 813-7654
Phase II – A021804
A Prospective, Multi-Institutional Phase II Trial Evaluating Temozolomide vs. Temozolomide and Olaparib for Advanced Pheochromocytoma and Paraganglioma
Alliance for Clinical Trials in Oncology
Del Rivero, Jaydira
(240) 805-2888
Phase II – AMC-107
A Phase 2 Trial of Ixazomib for Kaposi Sarcoma
AIDS Malignancy Consortium
Mitsuyasu, Ronald T.
(310) 825-6689
Phase II – EA8184
A Phase II Randomized Double Blinded Study of Green Tea Catechins (GTC) vs. Placebo in Men on Active Surveillance for Prostate Cancer: Modulation of Biological and Clinical Intermediate Biomarkers
ECOG-ACRIN Cancer Research Group
Kumar, Nagi B.
(813) 745-6885
Phase III – EA9181
A Phase III Randomized Trial of Steroids + Tyrosine Kinase Inhibitor Induction with Chemotherapy or Blinatumomab for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults
ECOG-ACRIN Cancer Research Group
Ofran, Yishai
+972-4-7772541
Phase III – EAA181
Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended for Early Autologous Transplantation
ECOG-ACRIN Cancer Research Group
Kumar, Shaji K.
(507) 284-2017
Phase III – NRG-BN009
Phase III Trial of Salvage Stereotactic Radiosurgery (SRS) or SRS + Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for First or Second Distant Brain Relapse After Upfront SRS with Brain Metastasis Velocity >/= 4 Brain Metastases/Year
NRG Oncology
Gondi, Vinai
(630) 821-6430
Phase Other – A231901CD
Improving Patient-Centered Communication in Breast Cancer: A RCT of a Shared Decision Engagement System (SHADES)
Alliance for Clinical Trials in Oncology
Hawley, Sarah
(734) 936-8816
